14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
TCMD vs MYO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Tactile Systems Technology, Inc. (TCMD) is the stronger overall head-to-head candidate over Myomo Inc. (MYO) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TCMD carries a Unified Composite Score of 40.1/100 (SELL) at $25.60 (17.4x Forward P/E, 9.4% operating margin), whereas MYO carries 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin).
Growth vs. Quality Trade-Off: TCMD earns the overall head-to-head edge with a stronger Unified Composite Score (40.1/100 SELL vs. MYO 40.1/100 SELL) and 0.95β · 52% Vol risk profile, whereas MYO leads top-line expansion (+22.2% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although TCMD compares more favorably head-to-head, both TCMD (40.1/100 SELL) and MYO (40.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: TCMD trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.6); meanwhile MYO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Medical Devices value chain with $33.7M market capitalization and -21.8% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ TCMD vs MYO Key Questions & Quantitative Answers
As of Nov 20, 2026, Tactile Systems Technology, Inc. (TCMD) is the stronger overall head-to-head candidate over Myomo Inc. (MYO) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TCMD carries a Unified Composite Score of 40.1/100 (SELL) at $25.60 (17.4x Forward P/E, 9.4% operating margin), whereas MYO carries 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin). Growth vs. Quality Trade-Off: TCMD earns the overall head-to-head edge with a stronger Unified Composite Score (40.1/100 SELL vs. MYO 40.1/100 SELL) and 0.95β · 52% Vol risk profile, whereas MYO leads top-line expansion (+22.2% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although TCMD compares more favorably head-to-head, both TCMD (40.1/100 SELL) and MYO (40.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: TCMD trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.6); meanwhile MYO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MYO leads the Growth & Scale pillar: TCMD posts +7.1% YoY revenue growth and -13.9% YoY earnings growth on $356M TTM revenue (77.0% gross margin, 9.4% operating margin), compared with MYO at +22.2% YoY revenue growth and +0.0% YoY earnings growth on $46M TTM revenue (70.1% gross margin, -21.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), TCMD cumulative revenue shifted +135.7% while MYO shifted +300.0%. In operating R&D and SG&A reinvestment, TCMD deploys 67.6% of Rev ($241M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MYO.
TCMD screens cheaper on headline valuation multiples. TCMD trades at 17.4x Forward P/E, 25.2x Trailing P/E, 17.79x PEG, and 1.5x EV/Revenue (8.1% FCF margin), whereas MYO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-20.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TCMD (11.0% ROE) versus MYO (-173.5% ROE) capital efficiency.
In options market volatility and institutional positioning, TCMD carries 54.9% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.95β · 52% Vol realized risk). By comparison, MYO carries 266.0% implied volatility (81st %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.22β · 107% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.